rs121918639
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_003126.4(SPTA1):c.145C>T(p.Leu49Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003126.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 50
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Elliptocytosis 2 Pathogenic:1
- -
Elliptocytosis 2;C2674219:Hereditary spherocytosis type 2 Uncertain:1
The heterozygous p.Leu49Phe variant in SPTA1 was identified by our study, with a likely pathogenic variant associated with spherocytosis, in one individual with elliptocytosis and spherocytosis. This variant was absent from large population studies and OMIM has reported this variant as Pathogenic in ClinVar (Variation ID: 12851). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In vitro functional studies and some computational tools provide some evidence that the p.Leu49Phe variant may impact protein function by affecting helical formation and tetramer binding (PMID: 18218854, 19593814, 18783249). However, these types of assays may not accurately represent biological function. In summary, although there is some suspicion for pathogenicity, the clinical significance of the p.Leu49Phe is uncertain. ACMG/AMP Criteria applied: PM2, PS3_Moderate (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at